4.5 Article

Myelin basic protein induces inflammatory mediators from primary human endothelial cells and blood-brain barrier disruption: implications for the pathogenesis of multiple sclerosis

Journal

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
Volume 39, Issue 3, Pages 270-283

Publisher

WILEY
DOI: 10.1111/j.1365-2990.2012.01279.x

Keywords

bloodbrain barrier; CCL2; EAE; IL-6; MBP; MS

Funding

  1. National Institutes of Mental Health [MH075679, MH070297, MH076679]
  2. National Institutes of Health [NS11920]
  3. National Institutes of Health Experimental Neuropathology Training Grant [NS07098]
  4. Immunology/Pathology core of the National Institutes of Health Center for AIDS Research [AI051519]

Ask authors/readers for more resources

T. G. D'Aversa, E. A. Eugenin, L. Lopez and J. W. Berman (2013) Neuropathology and Applied Neurobiology39, 270283 Myelin basic protein induces inflammatory mediators from primary human endothelial cells and bloodbrain barrier disruption: implications for the pathogenesis of multiple sclerosis Aim: Multiple sclerosis (MS) is an autoimmune disease of the central nervous system, characterized by demyelination of white matter, loss of myelin forming oligodendrocytes, changes in the bloodbrain barrier (BBB) and leucocyte infiltration. Myelin basic protein (MBP) is a component of the myelin sheath. Degradation of myelin is believed to be an important step that leads to MS pathology. Transmigration of leucocytes across the vasculature, and a compromised BBB participate in the neuroinflammation of MS. We examined the expression and regulation of the chemokine (CC motif) ligand 2 (CCL2) and the cytokine interleukin-6 (IL-6) in human endothelial cells (EC), a component of the BBB, after treatment with MBP. Methods: EC were treated with full-length MBP. CCL2 and IL-6 protein were determined by ELISA. Western blot analysis was used to determine signalling pathways. A BBB model was treated with MBP and permeability was assayed using albumin conjugated to Evan's blue dye. The levels of the tight junction proteins occludin and claudin-1, and matrix metalloprotease (MMP)-2 were assayed by Western blot. Results: MBP significantly induced CCL2 and IL-6 protein from EC. This induction was partially mediated by the p38 MAPK pathway as there was phosphorylation after MBP treatment. MBP treatment of a BBB model caused an increase in permeability that correlated with a decrease in occludin and claudin-1, and an induction of MMP2. Conclusion: These data demonstrate that MBP induces chemotactic and inflammatory mediators. MBP also alters BBB permeability and tight junction expression, indicating additional factors that may contribute to the BBB breakdown characteristic of MS.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available